Basal cell carcinoma - an in-vivo model of human tumour microcirculation?

Citation
Aj. Bedlow et al., Basal cell carcinoma - an in-vivo model of human tumour microcirculation?, EXP DERMATO, 8(3), 1999, pp. 222-226
Citations number
22
Categorie Soggetti
Dermatology
Journal title
EXPERIMENTAL DERMATOLOGY
ISSN journal
09066705 → ACNP
Volume
8
Issue
3
Year of publication
1999
Pages
222 - 226
Database
ISI
SICI code
0906-6705(199906)8:3<222:BCC-AI>2.0.ZU;2-0
Abstract
The role of angiogenesis in tumour growth and metastasis is well establishe d. However, investigations of tumour microcirculation to date have used eit her biopsy material from human tumours, or animal models in vivo. We have s tudied the tumour microcirculation in vivo in human skin cancers using vide o-microscopy to examine 12 basal cell carcinomas (BCCs) on the head and nec k of 11 patients, and compared the vessels with those seen in the peri-lesi onal skin, and in normal control skin on the opposite side of the body. The vessels seen within the BCCs were markedly abnormal qualitatively, forming bizarre, disorganized patterns. Quantitative analysis revealed that the me an diameter (+/-standard deviation) of the largest vessel was significantly greater within the BCC (0.086+/-0.029 mm) than that in the control skin (0 .034+/-0.012 mm) (P<0.001). The area fraction, a measure of the area of tis sue occupied by vessels, was increased highly significantly within the BCCs (0.158+/-0.038) compared with both peri-lesional skin (0.029+/-0.012) and control skin (0.027+/-0.010) (P<0.001). Length density, the length of blood vessel per unit area of tissue, was also highly significantly greater with in the lesion (210.22+/-66.05 cm(-1)) compared to peri-lesional (27.10+/-15 .67 cm(-1)) and control skin (28.27+/-15.81 cm(-1)) (P<0.001). This is the first study to have demonstrated that BCCs possess a distinct tumour microc irculation which can be observed directly, and assessed quantitatively. Pro spective studies of tumour progression, possibly after intervention with an giogenesis inhibitors, are possible.